vs
太平洋生物科学（ASMB）与Digimarc CORP（DMRC）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是Digimarc CORP的1.2倍（$10.8M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -85.2%，领先38.0%），太平洋生物科学同比增速更快（57.6% vs 2.9%），Digimarc CORP自由现金流更多（$895.0K vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
ASMB vs DMRC — 直观对比
营收规模更大
ASMB
是对方的1.2倍
$8.9M
营收增速更快
ASMB
高出54.7%
2.9%
净利率更高
DMRC
高出38.0%
-85.2%
自由现金流更多
DMRC
多$16.1M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $8.9M |
| 净利润 | $-9.2M | $-4.2M |
| 毛利率 | — | 63.5% |
| 营业利润率 | -100.9% | -48.2% |
| 净利率 | -85.2% | -47.2% |
| 营收同比 | 57.6% | 2.9% |
| 净利润同比 | 4.3% | 51.4% |
| 每股收益（稀释后） | $-0.72 | $-0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBDMRC
| Q4 25 | — | $8.9M | ||
| Q3 25 | $10.8M | $7.6M | ||
| Q2 25 | $9.6M | $8.0M | ||
| Q1 25 | $9.4M | $9.4M | ||
| Q4 24 | $7.4M | $8.7M | ||
| Q3 24 | $6.8M | $9.4M | ||
| Q2 24 | $8.5M | $10.4M | ||
| Q1 24 | $5.8M | $9.9M |
净利润ASMBDMRC
| Q4 25 | — | $-4.2M | ||
| Q3 25 | $-9.2M | $-8.2M | ||
| Q2 25 | $-10.2M | $-8.2M | ||
| Q1 25 | $-8.8M | $-11.7M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | $-9.6M | $-10.8M | ||
| Q2 24 | $-11.2M | $-9.3M | ||
| Q1 24 | $-9.1M | $-10.3M |
毛利率ASMBDMRC
| Q4 25 | — | 63.5% | ||
| Q3 25 | — | 58.3% | ||
| Q2 25 | — | 58.8% | ||
| Q1 25 | — | 65.0% | ||
| Q4 24 | — | 60.8% | ||
| Q3 24 | — | 62.4% | ||
| Q2 24 | — | 66.1% | ||
| Q1 24 | — | 62.5% |
营业利润率ASMBDMRC
| Q4 25 | — | -48.2% | ||
| Q3 25 | -100.9% | -109.7% | ||
| Q2 25 | -115.2% | -105.2% | ||
| Q1 25 | -105.5% | -128.9% | ||
| Q4 24 | — | -105.1% | ||
| Q3 24 | -160.1% | -120.4% | ||
| Q2 24 | -143.0% | -96.2% | ||
| Q1 24 | -185.5% | -109.2% |
净利率ASMBDMRC
| Q4 25 | — | -47.2% | ||
| Q3 25 | -85.2% | -106.9% | ||
| Q2 25 | -105.9% | -102.6% | ||
| Q1 25 | -93.6% | -125.2% | ||
| Q4 24 | — | -99.9% | ||
| Q3 24 | -140.4% | -113.9% | ||
| Q2 24 | -130.7% | -89.3% | ||
| Q1 24 | -156.9% | -104.0% |
每股收益（稀释后）ASMBDMRC
| Q4 25 | — | $-0.18 | ||
| Q3 25 | $-0.72 | $-0.38 | ||
| Q2 25 | $-1.33 | $-0.38 | ||
| Q1 25 | $-1.17 | $-0.55 | ||
| Q4 24 | — | $-0.40 | ||
| Q3 24 | $-1.51 | $-0.50 | ||
| Q2 24 | $-1.98 | $-0.43 | ||
| Q1 24 | $-1.66 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $12.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $40.2M |
| 总资产 | $240.0M | $53.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBDMRC
| Q4 25 | — | $12.9M | ||
| Q3 25 | $22.5M | $12.6M | ||
| Q2 25 | $24.0M | $16.1M | ||
| Q1 25 | $23.4M | $21.6M | ||
| Q4 24 | $38.3M | $28.7M | ||
| Q3 24 | $28.5M | $33.7M | ||
| Q2 24 | $19.2M | $41.5M | ||
| Q1 24 | $18.7M | $48.9M |
股东权益ASMBDMRC
| Q4 25 | — | $40.2M | ||
| Q3 25 | $182.7M | $41.4M | ||
| Q2 25 | $18.1M | $46.5M | ||
| Q1 25 | $27.1M | $50.0M | ||
| Q4 24 | $33.4M | $61.4M | ||
| Q3 24 | $26.0M | $70.2M | ||
| Q2 24 | $34.7M | $77.2M | ||
| Q1 24 | $32.6M | $84.5M |
总资产ASMBDMRC
| Q4 25 | — | $53.0M | ||
| Q3 25 | $240.0M | $55.4M | ||
| Q2 25 | $80.8M | $60.7M | ||
| Q1 25 | $99.0M | $66.5M | ||
| Q4 24 | $119.2M | $75.8M | ||
| Q3 24 | $100.3M | $85.0M | ||
| Q2 24 | $115.3M | $93.4M | ||
| Q1 24 | $119.9M | $99.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $991.0K |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $895.0K |
| 自由现金流率自由现金流/营收 | -140.7% | 10.0% |
| 资本支出强度资本支出/营收 | 0.4% | 1.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-12.3M |
8季度趋势，按日历期对齐
经营现金流ASMBDMRC
| Q4 25 | — | $991.0K | ||
| Q3 25 | $-15.1M | $-2.6M | ||
| Q2 25 | $-16.8M | $-4.7M | ||
| Q1 25 | $-23.4M | $-5.5M | ||
| Q4 24 | $-51.1M | $-4.2M | ||
| Q3 24 | $-15.2M | $-7.1M | ||
| Q2 24 | $-17.1M | $-6.8M | ||
| Q1 24 | $-18.4M | $-8.4M |
自由现金流ASMBDMRC
| Q4 25 | — | $895.0K | ||
| Q3 25 | $-15.2M | $-2.8M | ||
| Q2 25 | — | $-4.9M | ||
| Q1 25 | — | $-5.5M | ||
| Q4 24 | $-51.1M | $-4.2M | ||
| Q3 24 | — | $-7.2M | ||
| Q2 24 | $-17.1M | $-6.9M | ||
| Q1 24 | $-18.4M | $-8.5M |
自由现金流率ASMBDMRC
| Q4 25 | — | 10.0% | ||
| Q3 25 | -140.7% | -36.9% | ||
| Q2 25 | — | -61.0% | ||
| Q1 25 | — | -59.1% | ||
| Q4 24 | -695.2% | -49.1% | ||
| Q3 24 | — | -75.7% | ||
| Q2 24 | -200.6% | -66.1% | ||
| Q1 24 | -317.7% | -85.8% |
资本支出强度ASMBDMRC
| Q4 25 | — | 1.1% | ||
| Q3 25 | 0.4% | 2.9% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.4% | 0.2% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.2% | 0.3% | ||
| Q1 24 | 0.2% | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASMB
暂无分部数据
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
